Jupiter Neurosciences, Inc. Common Stock
JUNSJupiter Neurosciences, Inc. (JUNS) is a biopharmaceutical company focused on developing treatments for neurological and psychiatric disorders. The company specializes in advancing innovative therapies targeting unmet medical needs in the field of brain health.
$1.06 +0.02 (2.21%)
Company News
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6
Jupiter Neurosciences (NASDAQ: JUNS) announced a webinar on January 6, 2026, where CEO Chister Rosén will discuss the company's JOTROL™ resveratrol platform, upcoming Phase 2a Parkinson's disease trial, and commercialization of its Nugevia™ consumer product line. The company is pursuing a dual-path strategy combining pharmaceutical developme...
